Mallinckrodt faces Chapter 11 appeals, enters parallel Irish examinership

Health insurance companies that are appealing pharma manufacturer Mallinckrodt’s recently-confirmed Chapter 11 plan, have failed to obtain a stay on distributions pending appeal, as a court in Ireland relied on a 2016 precedent to open up parallel proceedings and appoint a Grant Thornton managing director as examiner.

Get unlimited access to all Global Restructuring Review content